Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
$301M in Q4 2021 → $665M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SE Space Exploration Techn Corp | 36.0% | New | 1,398,815 | $239M |
| Aktis Oncology Inc | 14.9% | Trimmed 2.9% | 3,070,219 | $99M |
| Cullinan Therapeutics Inc | 4.2% | Trimmed 19% | 1,539,764 | $28M |
| Larimar Therapeutics Inc | 4.2% | Added 29% | 9,163,157 | $27.9M |
| NC Nuveen Churchill Direct Lend | 4.0% | Unchanged | 2,143,626 | $26.6M |
| Maplight Therapeutics Inc | 3.9% | Trimmed 27% | 729,929 | $26.2M |
| CO Capital One Finl Corp | 3.6% | New | 119,757 | $24M |
| Blue Owl Capital Corporation | 3.3% | Unchanged | 2,045,070 | $22.2M |
| DF Deep Fission Inc | 2.2% | New | 1,333,333 | $14.7M |
| Dell Technologies Inc | 2.1% | Added 137% | 32,961 | $14.2M |
| Holley Inc | 1.7% | Added 3.3% | 4,376,888 | $11.2M |
| Eyepoint Inc | 1.6% | Trimmed 16% | 762,594 | $10.9M |
| Sagimet Biosciences Inc | 1.5% | Added 278% | 1,260,544 | $9.74M |
| Corvus Pharmaceuticals Inc | 1.4% | Added 12% | 608,600 | $9.09M |
| Artiva Biotherapeutics Inc | 1.3% | New | 874,542 | $8.48M |
| Compass Therapeutics Inc | 1.2% | Added 23% | 3,624,076 | $7.94M |
| Conduent Inc | 1.1% | Unchanged | 5,036,595 | $7.35M |
| Rhythm Pharmaceuticals Inc | 1.0% | Unchanged | 61,455 | $6.82M |
| Compass Pathways PLC | 1.0% | New | 450,000 | $6.37M |
| UP Ultragenyx Pharmaceutical In | 0.9% | Trimmed 40% | 182,638 | $6.1M |
| PT Palvella Therapeutics Inc Ne | 0.8% | Added 16% | 36,259 | $5.54M |
| Imagenebio Inc | 0.8% | Trimmed 4.3% | 917,692 | $5.41M |
| Compass Pathways PLC Call | 0.8% | New | 1,670,500 | $5.18M |
| Viridian Therapeutics Inc | 0.7% | New | 260,000 | $4.78M |
| Immix Biopharma Inc | 0.7% | Trimmed 20% | 437,552 | $4.51M |
| Oric Pharmaceuticals Inc | 0.7% | Added 167% | 400,000 | $4.33M |
| Lenz Therapeutics Inc | 0.6% | Added 49% | 756,722 | $4.3M |
| Aquestive Therapeutics Inc | 0.6% | Trimmed 30% | 942,932 | $3.92M |
| SP Starwood Ppty Tr Inc | 0.5% | Added 24% | 196,355 | $3.22M |
| Evommune Inc | 0.4% | Added 80% | 180,000 | $2.39M |
| Eledon Pharmaceuticals Inc | 0.3% | Trimmed 60% | 566,509 | $2.23M |
| Cabaletta Bio Inc | 0.3% | New | 714,710 | $2.22M |
| CF Chime Finl Inc | 0.3% | New | 89,878 | $1.84M |
| Context Therapeutics Inc | 0.2% | Trimmed 42% | 2,934,015 | $1.63M |
| WI Ww Intl Inc | 0.2% | Trimmed 12% | 84,399 | $1.35M |
| Marker Therapeutics Inc | 0.1% | Unchanged | 554,250 | $815K |
| Erasca Inc Call | 0.1% | New | 100,000 | $795K |
| AT Adc Therapeutics Sa | 0.1% | Unchanged | 733,568 | $785K |
| Cybin Inc | 0.1% | New | 59,911 | $396K |
| FH Fold Hldgs Inc | 0.1% | Unchanged | 856,632 | $385K |
| ND Niocorp Devs Ltd | 0.1% | Trimmed 16% | 268,280 | $381K |
| Eledon Pharmaceuticals Inc Call | 0.0% | New | 200,000 | $285K |
| Rezolve Ai PLC | 0.0% | Unchanged | 235,121 | $214K |
| Brand Engagement Network Inc | 0.0% | Trimmed 13% | 1,453,808 | $204K |
| Piper Sandler Companies | 0.0% | Unchanged | 2,428 | $176K |
| Engene Therapeutics Inc | 0.0% | New | 511,177 | $148K |
| Larimar Therapeutics Inc Call | 0.0% | New | 728,600 | $146K |
| Celcuity Inc | 0.0% | New | 1,249 | $131K |
| Compass Therapeutics Inc Call | 0.0% | New | 303,800 | $106K |
| Stablecoinx Inc | 0.0% | New | 250,000 | $103K |
| ET Energy Transfer L P | 0.0% | Unchanged | 5,326 | $102K |
| Caris Life Sciences Inc | 0.0% | Unchanged | 4,711 | $84K |
| Vodafone Group PLC | 0.0% | New | 5,371 | $71K |
| Dave Inc | 0.0% | Unchanged | 28,750 | $68.4K |
| MG Murano Global Invt PLC | 0.0% | New | 261,875 | $62.9K |
| AM Alpha Modus Hldgs Inc | 0.0% | Unchanged | 1,854,665 | $55.6K |
| Roadzen Inc | 0.0% | Unchanged | 225,000 | $42.8K |
| AM Alpha Modus Hldgs Inc | 0.0% | New | 9,853 | $42K |
| Aeon Biopharma Inc | 0.0% | Unchanged | 42,353 | $30.5K |
| SH Southland Hldgs Inc | 0.0% | Unchanged | 860,302 | $25.8K |
Showing top 60 of 76 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 11, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SE Space Exploration Techn Corp | New | +1,398,815 | +$239M | 36.0% |
| EH Engene Holdings Inc | Exited | −4,416,353 | −$30.1M | — |
| CO Capital One Finl Corp | New | +119,757 | +$24M | 3.6% |
| DF Deep Fission Inc | New | +1,333,333 | +$14.7M | 2.2% |
| Maplight Therapeutics Inc | Trimmed | −276,000 | −$9.89M | 3.9% |
| Artiva Biotherapeutics Inc | New | +874,542 | +$8.48M | 1.3% |
| Dell Technologies Inc | Added | +19,062 | +$8.22M | 2.1% |
| Sagimet Biosciences Inc | Added | +926,667 | +$7.16M | 1.5% |
| Cullinan Therapeutics Inc | Trimmed | −370,000 | −$6.74M | 4.2% |
| Compass Pathways PLC | New | +450,000 | +$6.37M | 1.0% |
Showing the 10 largest of 69 changes.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Aktis Oncology Inc | New | +3,161,348 | +$56.6M | 15.2% |
| Maplight Therapeutics Inc | Added | +678,871 | +$13.8M | 5.5% |
| Repare Therapeutics Inc | Exited | −3,443,659 | −$8.95M | — |
| Corvus Pharmaceuticals Inc | New | +545,000 | +$7.97M | 2.1% |
| EH Engene Holdings Inc | Added | +1,055,416 | +$7.19M | 8.1% |
| Procore Technologies Inc | Exited | −94,264 | −$6.86M | — |
| Eyepoint Inc | Added | +520,000 | +$6.7M | 3.2% |
| Dell Technologies Inc | Trimmed | −39,949 | −$6.56M | 0.6% |
| Cullinan Therapeutics Inc | Trimmed | −441,208 | −$6.27M | 7.3% |
| Context Therapeutics Inc | Trimmed | −2,343,891 | −$6.14M | 3.6% |
Showing the 10 largest of 73 changes.
quarter ended December 31, 2025 · filed February 20, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Evercommerce Inc | Exited | −1,641,929 | −$18.3M | — |
| Roivant Sciences Ltd | Trimmed | −725,000 | −$15.7M | 1.8% |
| NC Nuveen Churchill Direct Lend | Trimmed | −947,927 | −$12.6M | 8.8% |
| Procore Technologies Inc | New | +94,264 | +$6.86M | 2.1% |
| Disc Medicine Inc | Exited | −102,260 | −$6.76M | — |
| PT Palvella Therapeutics Inc Ne | Trimmed | −55,000 | −$5.76M | 1.3% |
| Maplight Therapeutics Inc | New | +327,058 | +$5.74M | 1.8% |
| Immix Biopharma Inc | New | +986,240 | +$5.16M | 1.6% |
| Korro Bio Inc | Exited | −105,000 | −$5.03M | — |
| UP Ultragenyx Pharmaceutical In | Trimmed | −209,800 | −$4.83M | 1.5% |
Showing the 10 largest of 56 changes.
quarter ended September 30, 2025 · filed November 12, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tourmaline Bio Inc | Exited | −997,107 | −$15.9M | — |
| Roivant Sciences Ltd | New | +988,249 | +$15M | 4.6% |
| NC Nuveen Churchill Direct Lend | Trimmed | −948,000 | −$13.1M | 13.2% |
| Mineralys Therapeutics Inc | Trimmed | −235,000 | −$8.91M | 1.2% |
| Tango Therapeutics Inc | Trimmed | −695,000 | −$5.84M | 0.3% |
| IO Ikena Oncology Inc | Exited | −4,091,118 | −$5.48M | — |
| Tempus Ai Inc | Exited | −80,167 | −$5.09M | — |
| UP Ultragenyx Pharmaceutical In | Added | +167,200 | +$5.03M | 3.9% |
| Dell Technologies Inc | Added | +31,486 | +$4.46M | 2.3% |
| Imagenebio Inc | New | +540,924 | +$4.41M | 1.4% |
Showing the 10 largest of 37 changes.
quarter ended June 30, 2025 · filed August 11, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Proshares Tr | Exited | −175,000 | −$10M | — |
| Tango Therapeutics Inc | Trimmed | −1,307,236 | −$6.69M | 1.3% |
| Tempus Ai Inc | New | +80,167 | +$5.09M | 1.6% |
| UP Ultragenyx Pharmaceutical In | Added | +102,000 | +$3.71M | 3.0% |
| E2open Parent Holdings Inc | Exited | −1,650,943 | −$3.3M | — |
| Conduent Inc | Trimmed | −1,240,602 | −$3.28M | 3.8% |
| Keros Therapeutics Inc | Exited | −266,033 | −$2.71M | — |
| SP Starwood Ppty Tr Inc | New | +131,461 | +$2.64M | 0.9% |
| Dell Technologies Inc | New | +20,848 | +$2.56M | 0.8% |
| Compass Pathways PLC | Trimmed | −905,914 | −$2.54M | 0.2% |
Showing the 10 largest of 47 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Klaviyo Inc | Exited | −1,078,770 | −$44.5M | — |
| PT Proshares Tr | New | +175,000 | +$10M | 3.2% |
| Acelyrin Inc | Exited | −2,783,946 | −$8.74M | — |
| Civeo Corp | New | +348,226 | +$8.01M | 2.6% |
| Holley Inc | Added | +2,327,746 | +$5.98M | 4.4% |
| Mineralys Therapeutics Inc | New | +206,296 | +$3.28M | 1.1% |
| Palvella Therapeutics Inc | Trimmed | −109,803 | −$3.07M | 1.3% |
| Compass Pathways PLC | Added | +974,590 | +$2.79M | 1.0% |
| Nextnav Inc | New | +198,760 | +$2.42M | 0.8% |
| Mereo Biopharma Group PLC | Exited | −672,809 | −$2.35M | — |
Showing the 10 largest of 49 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Proshares Tr | Exited | −325,000 | −$23.6M | — |
| Tourmaline Bio Inc | Trimmed | −451,080 | −$9.15M | 5.0% |
| Conduent Inc | Added | +2,262,437 | +$9.14M | 5.2% |
| Eledon Pharmaceuticals Inc | New | +1,959,912 | +$8.07M | 1.9% |
| Lanzatech Global Inc | Exited | −2,926,514 | −$5.59M | — |
| Tango Therapeutics Inc | New | +1,732,152 | +$5.35M | 1.2% |
| CI Ccc Intelligent Solutions Hl | Exited | −457,104 | −$5.05M | — |
| EP Eyepoint Pharmaceuticals Inc | New | +667,594 | +$4.97M | 1.1% |
| Klaviyo Inc | Trimmed | −119,500 | −$4.93M | 10.3% |
| SP Starwood Property Trust | Exited | −226,456 | −$4.62M | — |
Showing the 10 largest of 106 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| NC Nuveen Churchill Direct Lend | New | +4,039,553 | +$70.4M | 13.6% |
| PT Proshares Tr | New | +325,000 | +$23.6M | 4.5% |
| Conduent Inc | New | +3,363,022 | +$13.6M | 2.6% |
| Toast Inc | Exited | −322,578 | −$8.31M | — |
| Holley Inc | New | +2,543,588 | +$7.5M | 1.4% |
| UP Ultragenyx Pharmaceutical In | Trimmed | −105,000 | −$5.83M | 1.7% |
| Lanzatech Global Inc | New | +2,926,514 | +$5.59M | 1.1% |
| CI Ccc Intelligent Solutions Hl | New | +457,104 | +$5.05M | 1.0% |
| Viking Therapeutics Inc | Exited | −95,000 | −$5.04M | — |
| Tourmaline Bio Inc | Trimmed | −185,000 | −$4.76M | 7.6% |
Showing the 10 largest of 122 changes.
Loading...
